(VCYT) |
| 0 (0%) 10-10 18:21 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 42.92 |
| Resistance 1: | 36.75 |
| Pivot price: | 34.55 |
| Support 1: | 32.99 |
| Support 2: | 30.67 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.340 |
| Book Value | 15.530 |
| PEG Ratio | 0.00 |
| Gross Profit | 4.297 |
| Profit Margin (%) | 5.50 |
| Operating Margin (%) | 10.99 |
| Return on Assets (ttm) | 2.0 |
| Return on Equity (ttm) | 2.2 |
Company news
Thu, 09 Oct 2025
Veracyte's (VCYT) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Wed, 08 Oct 2025
Veracyte (NASDAQ:VCYT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Tue, 07 Oct 2025
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Tue, 07 Oct 2025
Veracyte (NASDAQ:VCYT) Insider Sells 8,349 Shares - MarketBeat
Tue, 07 Oct 2025
Insider Sale: Chief Scientific & Med Officer of $VCYT Sells 8,349 Shares - Quiver Quantitative
Tue, 07 Oct 2025
Will Veracyte (VCYT) Leverage PAM50 Data to Strengthen Its Position in Precision Oncology? - Sahm
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
